Concepedia

Mona El‐Gamil

ME

Statistics

Publications

38

Citations

10.2K

H-Index

33

Active since

1980

Affiliations

National Institutes of Health(Current)

National Cancer Institute

Weizmann Institute of Science

Center for Cancer Research

Toxicologie, Pharmacologie et Signalisation Cellulaire

Mona El‐Gamil is an author at National Institutes of Health specializing in medicine, immunotherapy, and immunology.

Top concepts

Publications per year

1980–2019

38

Publications

38

Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1

Paul F. Robbins, Richard A. Morgan, Steven A. Feldman et al. · Journal of Clinical Oncology · 2011 · 1.6K citations · Full text

Stabilization of β-Catenin by Genetic Defects in Melanoma Cell Lines

Bonnee Rubinfeld, Paul F. Robbins, Mona El‐Gamil et al. · Science · 1997 · 1.2K citations

Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells

Paul F. Robbins, Yong‐Chen Lu, Mona El‐Gamil et al. · Nature Medicine · 2013 · 1.1K citations · Full text

, , +13

A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response

Paul F. Robbins, Sadik H. Kassim, Thai L.N. Tran et al. · Clinical Cancer Research · 2014 · 780 citations · Full text

A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes.

Paul F. Robbins, Mona El‐Gamil, Yongfeng Li et al. · The Journal of Experimental Medicine · 1996 · 547 citations · Full text

, , +18

Rows per page

1–5 of 38